34.55

3.46% -1.24

After Hours: 34.55

Scholar Rock Holding Corp (SRRK)

Overview News Price History Option Chain Financials Discussions Forecast

Scholar Rock Holding Corp stock is traded at $34.55, with a volume of 663.66K. It is down -3.46% in the last 24 hours and down -8.18% over the past month. Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.

Previous Close:

$35.79

Open:

$35.67

24h Volume:

663.66K

Relative Volume:

0.76

Market Cap:

$3.27B

Revenue:

$47.30M

Net Income/Loss:

$-225.97M

P/E Ratio:

-14.70

EPS:

-2.35

Net Cash Flow:

$-188.86M

1W Performance:

-4.37%

1M Performance:

-8.18%

6M Performance:

+303.15%

1Y Performance:

+110.93%

1-Day Range:

$34.31

$36.09

1-Week Range:

$34.14

$37.30

52-Week Range:

$6.76

$46.98

Scholar Rock Holding Corp Stock (SRRK) Company Profile

Name

Scholar Rock Holding Corp

Sector

Healthcare (1169)

Industry

Biotechnology (679)

Phone

857-259-3860

Address

301 BINNEY STREET, CAMBRIDGE, MA

Employee

196

Twitter

@ScholarRock

Next Earnings Date

2024-11-12

Latest SEC Filings

SRRK's Discussions on Twitter

Compare SRRK with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SRRK Scholar Rock Holding Corp	34.55	3.27B	47.30M	-225.97M	-188.86M	-2.35
VRTX Vertex Pharmaceuticals Inc	502.92	129.14B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	680.61	74.41B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	581.21	35.31B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	241.75	31.30B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	254.57	27.35B	3.32B	-860.46M	-1.04B	-8.32

Scholar Rock Holding Corp Stock (SRRK) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-26-24	Reiterated	H.C. Wainwright	Buy
Oct-07-24	Reiterated	H.C. Wainwright	Buy
Mar-28-24	Initiated	Raymond James	Strong Buy
Oct-25-23	Upgrade	Jefferies	Hold → Buy
Apr-03-23	Resumed	Piper Sandler	Overweight
Sep-19-22	Resumed	H.C. Wainwright	Buy
Jul-12-22	Initiated	Truist	Buy
Mar-23-22	Initiated	H.C. Wainwright	Buy
Dec-22-21	Downgrade	Jefferies	Buy → Hold
Nov-19-21	Initiated	Piper Sandler	Overweight
Apr-26-21	Resumed	Credit Suisse	Outperform
Jan-11-21	Initiated	Credit Suisse	Outperform
Jan-06-21	Initiated	JP Morgan	Overweight
Mar-12-20	Initiated	Robert W. Baird	Outperform

View All

Scholar Rock Holding Corp Stock (SRRK) Latest News

Mar 13, 2025

Edward H. Myles Sells 142,292 Shares of Scholar Rock Holding Co. (NASDAQ:SRRK) Stock - MarketBeat

Mar 13, 2025

Scholar Rock (NASDAQ:SRRK) Trading Up 6.1%Here's Why - MarketBeat

Mar 13, 2025

Scholar Rock Holding Co. (NASDAQ:SRRK) Given Average Recommendation of "Buy" by Brokerages - MarketBeat

Mar 13, 2025

Scholar Rock Holding Co. (NASDAQ:SRRK) Given Average Recommendation of “Buy” by Brokerages - Defense World

Mar 13, 2025

Mar 12, 2025

Scholar Rock’s COO and CFO sells shares worth $5.07 million - Investing.com India

Mar 12, 2025

Scholar Rock’s COO and CFO sells shares worth $5.07 million By Investing.com - Investing.com South Africa

Mar 12, 2025